Related Experiment Videos
Human NADH:ubiquinone oxidoreductase
J Smeitink1, R Sengers, F Trijbels
1Nijmegen Center for Mitochondrial Disorders at the Department of Pediatrics, University Medical Center Nijmegen, The Netherlands. J.Smeitink@ckskg.azn.nl
Journal of Bioenergetics and Biomembranes
|November 7, 2001
Summary
NADH:ubiquinone oxidoreductase (Complex I) deficiency is linked to mitochondrial disorders. Genetic analysis reveals mutations in nuclear genes, aiding diagnosis of these complex conditions.
Area of Science:
- Biochemistry
- Genetics
- Cell Biology
Background:
- NADH:ubiquinone oxidoreductase (Complex I) is crucial for cellular respiration.
- Deficiency in Complex I activity is a primary cause of mitochondrial disorders, notably Leigh disease.
- Diagnosis relies on enzyme activity assays in skeletal muscle and fibroblast studies for prenatal testing.
Purpose of the Study:
- To detail the enzymic methods used for Complex I analysis.
- To present recent advancements in the genomics and cell biology of human Complex I.
- To investigate the genetic basis of Complex I deficiency in patients.
Main Methods:
- Enzyme complex activity measurement in skeletal muscle.
- Fibroblast studies for prenatal diagnosis.
- Comprehensive mutational analysis of nuclear Complex I genes.
Main Results:
- Mitochondrial DNA mutations account for 5-10% of Complex I deficiencies.
- Recent determination of all structural nuclear Complex I genes.
- Mutational analysis in 20 patients identified mutations in approximately 40% of nuclear genes.
Conclusions:
- Enzyme activity assays remain central to diagnosing Complex I deficiency.
- Genomic and cell biology advancements are improving our understanding of human Complex I.
- Nuclear gene mutations are a significant factor in Complex I deficiencies, necessitating comprehensive genetic analysis.